LONN

LONZA N

Stock SIX Swiss Exchange – Stock Market Prices, News & Analysis

Lonza is a Swiss company specializing in life sciences, providing products and services to the pharmaceutical, biotechnology, and agrochemical sectors.

Fr. 483.70
1.23 %

LONZA N

Fr. 483.70
1.23 %
LONN

Lonza is a Swiss company specializing in life sciences, providing products and services to the pharmaceutical, biotechnology, and agrochemical sectors.

Price history of LONZA N
Price history of LONZA N

Performance & Momentum

6 Months 13.05 %
1 Year 10.57 %
3 Years 11.94 %
5 Years 7.67 %

Strategic Analysis

LONZA N • 2026

Lonza positions itself as a key player in the life sciences by offering integrated contract manufacturing services, combining expertise in biotechnology, fine chemistry, and pharmaceuticals. Its ability to serve global clients in innovative sectors grants it a sustainable competitive advantage in a rapidly growing market.

Strengths
  • Broad service portfolio tailored to the pharmaceutical, biotechnology, and agrochemical industries.
  • Strong international presence and outreach to capture global opportunities.
  • Recognized expertise in contract manufacturing that cultivates a specialized and demanding customer base.
Weaknesses
  • Sensitivity to long cycles and significant investments inherent in contract manufacturing.
  • Recent performance decline over several periods, suggesting short-term challenges in growth or profitability.
Momentum

Current momentum is moderate with a downward trend in recent periods, reflecting a potentially disrupted market environment or operational difficulties. This dynamic calls for caution but may also signal an entry opportunity before a potential structural recovery.

Similar stocks to LONZA N

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone